Author, as appears in the article.: Vila-Corcoles A, Ochoa-Gondar O, Guzmán JA, Rodriguez-Blanco T, Salsench E, Fuentes CM, EPIVAC Study Group.
Department: Medicina i Cirurgia
URV's Author/s: Fuentes Bellido, Cruz Maria
Abstract: The 23-valent polysaccharide pneumococcal vaccine (PPV) is currently recommended in elderly and high-risk adults. However, its efficacy in preventing pneumococcal infections remains controversial. This study assessed the clinical effectiveness of vaccination against invasive pneumococcal disease (IPD) among people over 60 years.
Thematic Areas: Astronomia / física Biodiversidade Biotecnología Ciências ambientais Ciências biológicas i Ciências biológicas ii Ciências biológicas iii Enfermagem Engenharias i Engenharias iv Ensino Farmacia Infectious diseases Interdisciplinar Medicina i Medicina ii Medicina iii Medicina veterinaria Nutrição Odontología Saúde coletiva Zootecnia / recursos pesqueiros
licence for use: https://creativecommons.org/licenses/by/3.0/es/
Author's mail: cruzmaria.fuentes@urv.cat
ISSN: 1471-2334
Record's date: 2020-11-30
Journal volume: 10
Papper version: info:eu-repo/semantics/publishedVersion
Papper original source: Bmc Infectious Diseases. 10 (73): 73-
APA: Vila-Corcoles A, Ochoa-Gondar O, Guzmán JA, Rodriguez-Blanco T, Salsench E, Fuentes CM, EPIVAC Study Group. (2010). Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older. Bmc Infectious Diseases, 10(73), 73-. DOI: 10.1186/1471-2334-10-73
Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
Entity: Universitat Rovira i Virgili
Journal publication year: 2010
Publication Type: Journal Publications